Literature DB >> 1420449

Public acceptance of human gene therapy and perceptions of human genetic manipulation.

D R Macer1.   

Abstract

Clinical trials of gene therapy are underway in different countries, and further countries can be expected to use gene therapy soon. Little remains known, however, about public perceptions of gene therapy. Nationwide mail response opinion surveys were conducted in Japan in August-October, 1991. A total of 54% of the public, 65% of the high school biology teachers, and 54% of the scientists who responded said that they would be willing to use gene therapy, and 66%, 73%, and 62%, respectively, said that they would be willing to use gene therapy on their children. There appears to be growing acceptance of gene therapy in Japan, although about one-quarter of the population are against it. The underlying reasoning behind the acceptability of human genetic manipulation and perceived benefits and risks are presented, and these were found to be generally similar to reasoning expressed in a similar survey conducted in New Zealand in May, 1990. Public perceptions are also compared to those in Europe and the United States. People perceive both benefits and risks from genetic manipulation. There appears to be more teaching of ethical, social, and environmental issues associated with genetic engineering in senior high school biology classes in New Zealand than in Japan. In Japan and New Zealand, about 90% of the public would support including discussion of social issues associated with science and technology in the curriculum.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1992        PMID: 1420449     DOI: 10.1089/hum.1992.3.5-511

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  9 in total

1.  Public, experts, and acceptance of advanced medical technologies: the case of organ transplant and gene therapy in Japan.

Authors:  Hajime Sato; Akira Akabayashi; Ichiro Kai
Journal:  Health Care Anal       Date:  2006-12

2.  Informed consent, participation in, and withdrawal from a population based cohort study involving genetic analysis.

Authors:  K Matsui; Y Kita; H Ueshima
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

Review 3.  Human cancer and gene therapy.

Authors:  G Schmidt-Wolf; I G Schmidt-Wolf
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

4.  Identifying the public's knowledge and intention to use human cloning in Greek urban areas.

Authors:  Georgia Tzamalouka; Pelagia Soultatou; Maria Papadakaki; Sevasti Chatzifotiou; Basil Tarlatzis; Joannes El Chliaoutakis
Journal:  J Assist Reprod Genet       Date:  2005-02       Impact factor: 3.412

5.  Predicting human cloning acceptability: a national Greek survey on the beliefs of the public.

Authors:  Georgia S Tzamalouka; Maria Papadakaki; Pelagia Soultatou; Sevasti Chatzifotiou; Basil Tarlatzis; Joannes El Chliaoutakis
Journal:  J Assist Reprod Genet       Date:  2005-10       Impact factor: 3.412

6.  The attitude of oncology physicians and nurses to the acceptance of new drugs for gene therapy.

Authors:  Zi-ming Liu; Chang Liu; Jun-ying Li; Chun-hua Yu; Yu Jiang
Journal:  J Cancer Educ       Date:  2011-06       Impact factor: 2.037

7.  Reasons for being in favour of or against genome modification: a survey of the Dutch general public.

Authors:  S Hendriks; N A A Giesbertz; A L Bredenoord; S Repping
Journal:  Hum Reprod Open       Date:  2018-05-16

8.  Ethical Concerns About Human Genetic Enhancement in the Malay Science Fiction Novels.

Authors:  Noor Munirah Isa; Muhammad Fakhruddin Hj Safian Shuri
Journal:  Sci Eng Ethics       Date:  2017-03-09       Impact factor: 3.525

9.  Utilizing social media to study information-seeking and ethical issues in gene therapy.

Authors:  Julie M Robillard; Louise Whiteley; Thomas Wade Johnson; Jonathan Lim; Wyeth W Wasserman; Judy Illes
Journal:  J Med Internet Res       Date:  2013-03-04       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.